Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Abbott Laboratories Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $88.7 Billion
- Q1 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Abbott Laboratories stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 7,148,299 shares of ABT stock, worth $731 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
7,148,299
Previous 3,206,675
122.92%
Holding current value
$731 Million
Previous $353 Million
130.19%
% of portfolio
0.92%
Previous 0.46%
Shares
32 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$16.9 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.6 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.59 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.65 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.18 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $179B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...